Overview
Non-interventional, multi-center, long-term follow-up (LTFU) study of subjects dosed with ST-920 in the clinical study ST-920-201. All subjects dosed in the study who completed at least 52 weeks post-infusion follow-up in their primary protocol will be offered to participate. Subjects who enroll will be monitored for a total of up to 5 years following ST-920 infusion.
Principal investigator
Eligibility criteria
Inclusion Criteria:
* Subjects who received ST-920 therapy in a separate parent trial
* Subjects who have consented to participate in this LTFU study.
Exclusion Criteria: -This study has no exclusion criteria
* Subjects who received ST-920 therapy in a separate parent trial
* Subjects who have consented to participate in this LTFU study.
Exclusion Criteria: -This study has no exclusion criteria
Participate in this trial
Are you interested in enrolling in this study? Learn more here.
I'm Interested In ParticipatingFor Referring Providers
Do you have a patient you think would be a good candidate for this trial? Learn more about enrolling your patient.